Colombia Reaches COVID-19 Vaccine Agreements With Moderna, Sinovac

Colombia previously announced agreements to secure 10 million doses each of vaccines developed by Pfizer Inc and BioNTech SE, and AstraZeneca PLC, as well as 9 million doses of a vaccine developed by Janssen, the pharmaceutical wing of Johnson & Johnson.

RIO DE JANEIRO, BRAZIL - Colombia has reached agreements for doses of COVID-19 vaccines developed by Moderna Inc and Sinovac Biotech Ltd and plans to begin a mass vaccination campaign on February 20th, President Ivan Duque said on Friday, January 29th.

The Andean country’s government aims have at least 1 million people vaccinated against the novel coronavirus by the end of March, Duque added. Colombia, a country of about 50 million people, hopes to vaccinate some 34 million people in a bid to achieve what is known as herd immunity, when a large part of a given population becomes . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?